Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

被引:130
作者
Husted, Steen
de Caterina, Raffaele [1 ,2 ]
Andreotti, Felicita [3 ]
Arnesen, Harald [4 ]
Bachmann, Fedor [5 ]
Huber, Kurt [6 ]
Jespersen, Jorgen [7 ]
Kristensen, Steen Dalby [8 ]
Lip, Gregory Y. H. [9 ]
Morais, Joao [10 ]
Rasmussen, Lars H. [11 ,12 ]
Siegbahn, Agneta [13 ,14 ]
Storey, Robert F. [15 ]
Weitz, Jeffrey I. [16 ,17 ]
机构
[1] Univ G DAnnunzio, Inst Cardiol, Chieti, Italy
[2] Univ G DAnnunzio, Ctr Excellence Aging, Chieti, Italy
[3] Catholic Univ, Dept Cardiovasc Sci, Rome, Italy
[4] Oslo Univ Hosp, Dept Cardiol, Ctr Clin Heart Res, Oslo, Norway
[5] Univ Lausanne, CH-1015 Lausanne, Switzerland
[6] Wilhelminenspital Stadt Wien, Dept Med 3, Vienna, Austria
[7] Univ Southern Denmark, Inst Publ Hlth, Unit Thrombosis Res, Odense, Denmark
[8] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[9] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England
[10] Santo Andres Hosp, Div Cardiol, Leiria, Portugal
[11] Aalborg Univ, Dept Clin Med, Thrombosis Res Ctr, Fac Med, Aalborg, Denmark
[12] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark
[13] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
[14] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden
[15] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England
[16] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada
[17] McMaster Univ, Hamilton, ON, Canada
关键词
ESC WORKING GROUP; ATRIAL-FIBRILLATION; HEART-DISEASE; TASK-FORCE; POSITION PAPER; THROMBOSIS; GUIDELINES;
D O I
10.1160/TH14-03-0228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:781 / 782
页数:2
相关论文
共 12 条
  • [1] [Anonymous], 2014, CHEST
  • [2] Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]
  • [3] Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1087 - 1107
  • [4] Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (05) : 769 - 786
  • [5] General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (04) : 569 - 579
  • [6] New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease Position Paper
    De Caterina, Raffaele
    Husted, Steen
    Wallentin, Lars
    Andreotti, Felicita
    Arnesen, Harald
    Bachmann, Fedor
    Baigent, Colin
    Huber, Kurt
    Jespersen, Jorgen
    Kristensen, Steen Dalby
    Lip, Gregory Y. H.
    Morais, Joao
    Rasmussen, Lars Hvilsted
    Siegbahn, Agneta
    Verheugt, Freek W. A.
    Weitz, Jeffrey I.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (16) : 1413 - 1425
  • [7] Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation
    Gallego, Pilar
    Roldan, Vanessa
    Marin, Francisco
    Romera, Marta
    Valdes, Mariano
    Vicente, Vicente
    Lip, Gregory Y. H.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1189 - 1198
  • [8] European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
    Heidbuchel, Hein
    Verhamme, Peter
    Alings, Marco
    Antz, Matthias
    Hacke, Werner
    Oldgren, Jonas
    Sinnaeve, Peter
    Camm, A. John
    Kirchhof, Paulus
    [J]. EUROPACE, 2013, 15 (05): : 625 - 651
  • [9] Bleeding and antidotes in new oral anticoagulants
    Majeed, Ammar
    Schulman, Sam
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 191 - 202
  • [10] Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
    Ogilvie, Isla M.
    Newton, Nick
    Welner, Sharon A.
    Cowell, Warren
    Lip, Gregory Y. H.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2010, 123 (07) : 638 - U86